(Press-News.org) April 11, 2013, Fort Lauderdale, Fla. -- A new study suggests that the type of bio-cellular grafts increasingly used by surgeons to repair damaged tissue may be useful for treating low-back pain (LBP). However, not all sufferers responded equally to the novel therapy. Results reported today at the 29th Annual Meeting of the American Academy of Pain Medicine ranged from complete pain relief to no improvement.
The procedure involved injecting a concentrated form of bone-marrow cellular aspirate into lumbar discs in patients with clinical and objective evidence of disc degeneration. The results were reported in a poster authored by researchers from the Columbia Interventional Pain Center in Columbia, Mo., and the Bluetail Medical Group in Chesterfield, Mo.
"The results of our case review are encouraging," said Donald J. Meyer, MD, PhD, the study's primary author. "Currently, when conservative treatment measures fail, therapeutic options are limited for individuals with back pain due to disc degeneration. Many resort to disc surgery or spinal fusion with mediocre results. Our goal is to help develop a safe, natural method to boost the body's own capacity to heal discogenic pain."
The practice of using autologous grafts, in which material is transferred from within the same individual's body, has evolved beyond the simple use of platelet-rich plasma to encompass cellular bone-marrow concentrate and cells drawn from body fat, the study authors explained. Intrigued by the technique's possibilities in treating LBP, the team retrospectively examined data for 22 consecutive patients treated at Columbia Interventional Pain Center in Columbia, Mo., over 18 months. Patients had LBP lasting an average of 4 years along with evidence confirming degenerative disc changes via CT scan or MRI. Some patients also complained of leg pain.
Patients were informed of the study's experimental nature and gave informed consent. During the procedure, investigators harvested 60 cc iliac bone-marrow aspirate and concentrated it in a centrifuge to obtain bone-marrow aspirate cellular concentrate (BMAC). They then injected BMAC into each affected lumbar disc annulus using a 22-gauge Chiba needle under fluoroscopy. This was followed by the injection of an additional small amount of BMAC immediately external to the annulus. A maximum of 2 discs were treated.
At 5-24 months following treatment, patients reported changes in back pain ranging from complete pain relief to no improvement. No patient reported a worsening of pain, and no complications occurred. All subjects who experienced pain relief also reported significant improvement in activity tolerance or a reduction in pain medication use, or both.
A future prospective study is warranted, the authors concluded, to examine whether
biologic autograft treatment may provide a safe and effective therapy for lumbar discogenic pain.
###
Poster 203 - Lumbar Disc Biologic Autograft Injection of Bone Marrow Concentrate for Treatment of Low Back Pain: Retrospective Review of 22 Consecutive Cases
About AAPM
The American Academy of Pain Medicine is the premiere 2,400-member medical association for pain physicians and their treatment teams. Now in its 30th year of service, the Academy's mission is to optimize the health of patients in pain and eliminate it as a major public health problem by advancing the practice and specialty of pain medicine through education, training, advocacy and research. Information is available on the Academy's website at http://www.painmed.org.
Experimental study suggests bone-marrow grafts show promise for some sufferers of low-back pain
2013-04-12
ELSE PRESS RELEASES FROM THIS DATE:
High-dose opioids disturb hormones long-term, but mental and physiologic function improves
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows. The results, reported today at the 29th Annual Meeting of the American Academy of Pain Medicine, present rare data on the effects of opioids beyond 10 years. Most clinical trials that examine opioid use are of short duration, and little is known about long-term outcomes, particularly in patients who suffer from noncancer pain.
The 40 ...
Full range of treatment settings and their effects on radiofrequency heat lesion size
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Changing the parameters used to deliver radiofrequency (RF) treatment greatly affects the size of the resulting heat lesion, researchers reported today in a study expected to deliver greater precision and more treatment options in interventional pain management. Results were presented at the 29th Annual Meeting of the American Academy of Pain Medicine.
"This is the most comprehensive study of radiofrequency heat lesion size for pain management to date," said the study's lead author, Eric Cosman Jr., PhD, scientific director of ...
New techniques reduce the complications of spinal cord stimulator implant
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Two innovative techniques in the placement of an implanted spinal cord stimulator (SCS) are expected to reduce common complications at the implant site, according to new research revealed today. Results from a case series highlighted an advanced lead anchoring technique and the emerging technology of using large single-port introducers, which enable placement of multiple neurostimulation leads through a single needle-entry point.
Neurostimulation leads are used in SCS therapy for the management of chronic pain. The researchers ...
Web-based tools found to enhance recruitment and prescreening for clinical pain trials
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period. An innovative website allowed recruiters to reach out broadly to target and recruit potential subjects and to avoid many of the common difficulties of pain research, according to results presented today at the 29th Annual Meeting of the American Academy of Pain Medicine.
Research is important to establish which therapies are safe ...
Research shows promise for microwave ablation (MWA) to relieve painful bone and soft-tissue tumors
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation. Pain relief lasted over 4 months on average and up to 15 months in some patients, according to results reported at the 29th Annual Meeting of the American Academy of Pain Medicine.
Approximately 10,600 new cases of soft-tissue sarcoma and 2,570 new cases of bone sarcoma were diagnosed in the United States in 2009, according ...
Researchers measure reaction rates of second key atmospheric component
2013-04-12
LIVERMORE, Calif.— Researchers at Sandia National Laboratories' Combustion Research Facility, the University of Manchester, Bristol University, University of Southampton and Hong Kong Polytechnic have successfully measured reaction rates of a second Criegee intermediate, CH3CHOO, and proven that the reactivity of the atmospheric chemical depends strongly on which way the molecule is twisted.
The measurements will provide further insight into hydrocarbon combustion and atmospheric chemistry. A paper describing the research findings titled "Direct Measurements of Conformer-Dependent ...
Are 4 antenatal visits enough?
2013-04-12
Reanalysis of the World Health Organization's Antenatal Care Trial (WHOACT) shows that there is an increased risk of fetal death at between 32 and 36 weeks for women who have a reduced antenatal care package, finds research published in BioMed Central's open access journal Reproductive Health.
Original analysis of the WHOACT concluded that reducing antenatal visits of low risk women from eight to four was not detrimental to their or their babies' health and could cut costs. Based on this advice some countries have lowered the number of routine antenatal visits .
However, ...
Tiny wireless device shines light on mouse brain, generating reward
2013-04-12
AUDIO:
Scientists at Washington University School of Medicine in St. Louis and the University of Illinois in Urbana-Champaign, developed a tiny, light-emitting device that can activate and control neurons in the...
Click here for more information.
Using a miniature electronic device implanted in the brain, scientists have tapped into the internal reward system of mice, prodding neurons to release dopamine, a chemical associated with pleasure.
The researchers, at Washington ...
Sediba's ribcage and feet were not suitable for running
2013-04-12
Researchers at Wits University in South Africa, including Peter Schmid from the University of Zurich, have described the anatomy of a single early hominin in six new studies. Australopithecus sediba was discovered near Johannesburg in 2008. The studies in Science demonstrate how our two million year old ancestor walked, chewed and moved.
The fossils discovered four years ago in Malapa near Johannesburg show a mixture of primitive features of australopiths and advanced features of later human species. The researchers led by Prof Lee Berger of Wits University are therefore ...
Self-medication in animals much more widespread than believed
2013-04-12
ANN ARBOR—It's been known for decades that animals such as chimpanzees seek out medicinal herbs to treat their diseases. But in recent years, the list of animal pharmacists has grown much longer, and it now appears that the practice of animal self-medication is a lot more widespread than previously thought, according to a University of Michigan ecologist and his colleagues.
Animals use medications to treat various ailments through both learned and innate behaviors. The fact that moths, ants and fruit flies are now known to self-medicate has profound implications for the ...